Our Story

In a time of unparalleled advancement in genetic research, many people have yet to access the benefits of genomic medicine. Genome Medical was created to change that, by ensuring the lifelong journey of genomic medicine becomes accessible to everyone.

Lisa Alderson

Co-Founder and Chief Executive Officer

Lisa has 20 years of experience building early-stage companies with a focus on technology, consumer and life sciences businesses. Prior to Genome Medical, Lisa served as the Chief Commercial Officer and Chief Strategy Officer of Invitae (NYSE: NVTA), a rapidly growing genetic information company. She was part of the start-up team at Genome Health Inc. (Nasdaq: GHDX), president of Cinema Circle Inc. and the former manager of strategic planning at The Walt Disney Co.

Randy Scott, PhD

Co-Founder and Chairman

Randy is Chairman of Invitae, a company he co-founded and where he previously served as CEO. He also founded Genomic Health and served as Genomic Health’s Chief Executive Officer from 2000 until 2009 and Executive Chairman until 2012. Under Randy’s leadership, Genomic Health developed and launched two revolutionary cancer diagnostics tests. At Incyte, Randy served in various roles from 1991 through 2000, including Chairman of the Board, President and Chief Scientific Officer.

Robert Green, MD, MPH

Co-Founder and Scientific Advisory Board Chair

Dr. Green is co-founder and chairman of Genome Medical’s Scientific Advisory Board. He is a medical geneticist and physician-scientist who directs the G2P Research Program in translational genomics and health outcomes in the Division of Genetics at Brigham and Women’s Hospital and Harvard Medical School. Dr. Green is principal investigator of the MedSeq Project, the first NIH-funded randomized trial to explore the use of whole genome sequencing in the clinical practice of medicine.

W e are a nationwide genomics medical practice bringing genetics to everyday life. Our clinical team provides expert genetic health care for individuals and families to improve health and well-being. We also help clinicians and patients navigate the rapidly expanding field of genetic testing and use test results to understand disease risk, speed diagnosis, make informed treatment decisions and lower the cost of care.

Genome Medical was founded in 2016 by genetics industry leaders Lisa Alderson, MBA; Randy Scott, PhD, executive chairman of Invitae and founder of Genomic Health; and Robert C. Green, MD, MPH, a medical geneticist who directs the Genomes2People Research Program at Brigham and Women’s Hospital, is an associate member of the Broad Institute and is professor of medicine at Harvard Medical School.

Genome Medical is a mission-driven organization bringing genomic medicine to everyday care. We are delivering the future of healthcare today through our nationwide network of clinical genetics experts and our efficient genomic care delivery platform. Our team is dedicated to improving patient health and reducing the cost of healthcare delivery.

Lisa AldersonCo-founder and Chief Executive Officer

Backed by some of the strongest

World Class Investors

Genome Medical is privately funded. Its Series A funding was led by Canaan Partners with investors Flywheel Ventures, HealthInvest Equity Partners and Illumina Ventures. GE Ventures led the second round of funding, with new strategic investor Kaiser Permanente Ventures joining and additional investments from Canaan Partners and Illumina Ventures.